Moss Genomics Inc. — Investor Relations & Filings
Moss Genomics Inc. is a biotechnology company specializing in genomics and microbiome research, dedicated to developing advanced genetic insights and personalized health solutions. The company's core offering is a blockchain-based platform designed for the private, secure storage and monetization of individual genomic data. Recent corporate strategy has emphasized significant integration with digital assets, positioning the company as a hybrid entity. This strategy includes substantial investments in Ethereum (ETH) and participation in cryptocurrency mining operations, such as Bitcoin Cash (BCH), alongside its consumer genomics initiatives.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 52-109FV2 - Certification of interim filings - CEO (E).pdf | 2026-03-02 | English | |
| Interim MD&A - English.pdf | 2026-03-02 | English | |
| Interim financial statements/report – English.pdf | 2026-03-02 | English | |
| News release - English.pdf | 2026-01-05 | English | |
| 52-109FV2 - Certification of interim filings - CFO (E).pdf | 2025-12-02 | English | |
| Interim MD&A - English.pdf | 2025-12-01 | English |
Browse filings by year
5 yearsMarket data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Predict S.p.A.
Develops and distributes AI medical solutions for imaging, …
|
PRE | IT | Professional, scientific and te… |
|
PRESCIENT THERAPEUTICS LIMITED
Clinical-stage oncology firm developing modular cell therap…
|
PTX | AU | Professional, scientific and te… |
|
PreveCeutical Medical
Health sciences company researching and developing innovati…
|
PREV | CA | Professional, scientific and te… |
|
ProMIS Neurosciences Inc.
Develops selective antibody therapeutics for neurodegenerat…
|
PMN | CA | Professional, scientific and te… |
|
Propanc Biopharma, Inc.
Clinical-stage company developing cancer treatments to prev…
|
PPCB | US | Professional, scientific and te… |
|
ProQR Therapeutics N.V.
Develops RNA therapies for severe genetic disorders using i…
|
PRQR | NL | Professional, scientific and te… |
|
Prostatype Genomics AB
Develops a genetic test that assesses prostate cancer aggre…
|
PROGEN | SE | Professional, scientific and te… |
|
Protagenic Therapeutics, Inc.\new
Develops peptide-based therapeutics for stress-related neur…
|
PTIX | US | Professional, scientific and te… |
|
Protara Therapeutics, Inc.
Clinical-stage biopharma developing therapies for cancer an…
|
TARA | US | Professional, scientific and te… |
|
PROTEINA CO.,LTD.
A biotech firm analyzing protein interactions for drug and …
|
468530 | KR | Professional, scientific and te… |
Moss Genomics Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/48378/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=48378 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=48378 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=48378 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 48378}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Moss Genomics Inc. (id: 48378)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.